T. Rowe Price Investment Management, Inc. Exact Sciences Corp Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 322,406 shares of EXAS stock, worth $17.4 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
322,406
Previous 2,919,029
88.96%
Holding current value
$17.4 Million
Previous $126 Million
86.44%
% of portfolio
0.01%
Previous 0.08%
Shares
12 transactions
Others Institutions Holding EXAS
# of Institutions
651Shares Held
157MCall Options Held
1.43MPut Options Held
2.3M-
Capital World Investors Los Angeles, CA18.2MShares$981 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.9MShares$965 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$650 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12MShares$647 Million0.12% of portfolio
-
State Street Corp Boston, MA5.38MShares$290 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.54B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...